The Clinical Decision Support App Market Size is valued at USD 26.37 Bn in 2023 and is predicted to reach USD 40.56 Bn by 2031 at a 5.66% CAGR during the forecast period for 2024-2031.
Clinical decision support (CDS) apps provide real-time, evidence-based information to physicians to improve patient care. They provide ideas, alerts, and instructions based on integrated health data and optimum approaches to reduce healthcare errors and improve decision-making.
Clinical decision assistance applications are increasing rapidly due to the adoption of digital health technologies, focus on patient safety, advancements in healthcare infrastructure, strong regulatory frameworks supporting innovation and data privacy, and the development of specialized and patient-centric CDS Solutions. Establishing clear data-sharing policies, fostering interoperable electronic health records, and funding for digital health advances are crucial. These efforts are expected to improve the use of clinical decision support systems globally. However, data privacy and security concerns and inadequate interoperability for patient management solutions are expected to hinder market growth.
The clinical decision support app market is segmented based on delivery platform, end user, and application. Based on the delivery platform, the market is segmented as web-based CDS apps and mobile-based CDS apps. By end user, the market is segmented into hospitals and clinics, ambulatory care centres, long-term care facilities and others. The market is segmented by application into diagnostic support, treatment decision support, drug interactions, and safety.
The drug interactions and safety category is expected to hold a major share of the global clinical decision support app market in 2024. Drug allergy warnings are crucial interventions because limiting adverse drug reactions (ADRs) and allergic responses to drugs might harm patient well-being. Healthcare facilities strive to safeguard the well-being and security of their patients and hence rely on CDSS, which offers effective drug allergy warning features that may mitigate the risk of medication-related injury. Moreover, drug allergy continues to be a common phenomenon since it is observed that over 33% of patients have some allergic response to medications.
The web-based CDS apps segment is projected to grow at a rapid pace in the global clinical decision support app market due to its accessibility and scalability. These can be accessed from any device with internet access, are easy to update and maintain, and are integrated with other web-based systems. Thus, HCPs can access critical selection support equipment and individual information, facilitating seamless collaboration, faraway consultations, and continuity of care.
The North American clinical decision support apps market is leading the way, mainly because of the substantial demand for healthcare IT solutions, the presence of key players, rising significant investments in HCIT solutions, and the focus on providing high-quality healthcare services. In addition, the Asia Pacific region is estimated to grow rapidly in the clinical decision support apps market. The expansion is propelled by a vast population base and rising investments in healthcare, AI, analytics, and healthcare innovation, as well as healthcare providers' adoption of CDS apps to improve diagnostic accuracy and provide personalized patient care.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 26.37 Bn |
|
Revenue Forecast In 2031 |
USD 40.56 Bn |
|
Growth Rate CAGR |
CAGR of 5.66 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Delivery Platform, End-users, Applications, |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Epic, Cerner, Athenahealth, NextGen Healthcare, Evident Health, eClinicalWorks, DrChrono, McKesson, Wolters Kluwer, IBM Watson Health, Nuance, Philips, GE Healthcare, Siemens Healthineers, and Eclipsys Solutions (NTT DATA) |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Clinical Decision Support Market Snapshot
Chapter 4. Global Clinical Decision Support Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Delivery Platform Estimates & Trend Analysis
5.1. By Delivery Platform & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Delivery Platform:
5.2.1. Web-Based CDS Apps
5.2.2. Mobile-Based CDS Apps
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
6.2.1. Diagnostic Support
6.2.2. Treatment Decision Support
6.2.3. Drug Interactions and Safety
6.2.4. Others
Chapter 7. Market Segmentation 3: By End-User Estimates & Trend Analysis
7.1. By End-User & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-User:
7.2.1. Hospitals and Clinics
7.2.2. Ambulatory Care Centers
7.2.3. Long-Term Care Facilities
7.2.4. Others
Chapter 8. Clinical Decision Support Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by Delivery Platform, 2024-2031
8.1.2. North America Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.3. North America Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
8.1.4. North America Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by Delivery Platform, 2024-2031
8.2.2. Europe Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.3. Europe Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
8.2.4. Europe Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by Delivery Platform, 2024-2031
8.3.2. Asia Pacific Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.3. Asia Pacific Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
8.3.4. Asia Pacific Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Asia Pacific Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by Delivery Platform, 2024-2031
8.4.2. Latin America Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.3. Latin America Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
8.4.4. Latin America Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by Delivery Platform, 2024-2031
8.5.2. Middle East & Africa Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.3. Middle East & Africa Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
8.5.4. Middle East & Africa Clinical Decision Support Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Epic
9.2.2. Cerner
9.2.3. Athenahealth
9.2.4. NextGen Healthcare
9.2.5. Evident Health
9.2.6. eClinicalWorks
9.2.7. DrChrono
9.2.8. McKesson
9.2.9. Wolters Kluwer
9.2.10. IBM Watson Health
9.2.11. Nuance
9.2.12. Philips
9.2.13. GE Healthcare
9.2.14. Siemens Healthineers
9.2.15. Eclipsys Solutions (NTT DATA)
9.2.16. Other Prominent Players
By Delivery Platform -
By End User -
By Application-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
